DUSA Pharmaceuticals (DUSA) Reports In-Line Q2 EPS of 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $56.65 -0.18%
Financial Fact:
General and administrative: 2.91M
Today's EPS Names:
GFL, NHTC, SKHY, More
Financial Fact:
General and administrative: 2.91M
Today's EPS Names:
GFL, NHTC, SKHY, More
Join SI Premium – FREE
DUSA Pharmaceuticals (NASDAQ: DUSA) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $11.7 million versus the consensus estimate of $11.85 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q4 EPS by 29c; offers guidance
- Wex, Inc. (WEX) Tops Q3 EPS by 48c; offers guidance
- Fortinet (FTNT) Tops Q3 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
